January 16, 2023

Dr. Schleyer in HIT Consultant

Regenstrief Institute

Regenstrief Research Scientist Titus Schleyer, DMD, PhD, discussed his study surveying the current landscape of FHIR apps.

Read the HIT Consultant Article
The Latest
Research letter calls for careful consideration of design and consequences of health disparity incentives in future value-based payment models
News

Research letter calls for careful consideration of design and consequences of health disparity incentives in future value-based payment models

Regenstrief Institute conference highlights innovations in public health data modernization
News

Regenstrief Institute conference highlights innovations in public health data modernization

Supply, demand, and a growing US kidney transplant waiting list
Influence

Supply, demand, and a growing US kidney transplant waiting list

Dr. Grannis: What the data shows about prescribing, dispensing of antiviral flu meds
Video

Dr. Grannis: What the data shows about prescribing, dispensing of antiviral flu meds

Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy
Influence

Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy

Study reveals gaps in flu treatment for high-risk adults
News

Study reveals gaps in flu treatment for high-risk adults